Ninghan Feng

3.2k total citations
126 papers, 2.2k citations indexed

About

Ninghan Feng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ninghan Feng has authored 126 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 29 papers in Cancer Research and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ninghan Feng's work include Urinary Tract Infections Management (13 papers), Gut microbiota and health (11 papers) and Circular RNAs in diseases (11 papers). Ninghan Feng is often cited by papers focused on Urinary Tract Infections Management (13 papers), Gut microbiota and health (11 papers) and Circular RNAs in diseases (11 papers). Ninghan Feng collaborates with scholars based in China, United States and Sweden. Ninghan Feng's co-authors include Yong Q. Chen, Fengping Liu, Yihai Cao, Hao Zhang, Wei Chen, Xiaojuan Yang, Yuwei Zhang, Jia Sun, Lingling Jia and Di Qin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ninghan Feng

111 papers receiving 2.2k citations

Peers

Ninghan Feng
Yunshan Wang China
Shiming Yang China
Carlos Fernández-Patrón Canada
Shanling Liu China
Feng Kong China
Xing Zhang China
Jian Pan China
Weijun Liu China
Yunshan Wang China
Ninghan Feng
Citations per year, relative to Ninghan Feng Ninghan Feng (= 1×) peers Yunshan Wang

Countries citing papers authored by Ninghan Feng

Since Specialization
Citations

This map shows the geographic impact of Ninghan Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ninghan Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ninghan Feng more than expected).

Fields of papers citing papers by Ninghan Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ninghan Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ninghan Feng. The network helps show where Ninghan Feng may publish in the future.

Co-authorship network of co-authors of Ninghan Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Ninghan Feng. A scholar is included among the top collaborators of Ninghan Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ninghan Feng. Ninghan Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Menglu, Qi Sun, Yuwei Zhang, et al.. (2025). Probiotic domestication and engineering enable one-shot treatment for bladder mucosal repair. Biomaterials. 318. 123123–123123. 2 indexed citations
2.
Chen, Yao, Yongcheng Ren, Mingkun Chen, et al.. (2025). Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway. Molecular Medicine. 31(1). 30–30.
3.
Zhang, Jianye, Qi Zhang, Ying Wang, et al.. (2025). Single‐Cell Analysis Reveals that Vitamin C Inhibits Bone Metastasis of Renal Cancer via Cell Cycle Arrest and Microenvironment Remodeling. Advanced Science. 12(30). e01011–e01011. 1 indexed citations
4.
Shen, Zhenya, et al.. (2025). DLGAP5 upregulates E2F1 to promote prostate adenocarcinoma neuroendocrine differentiation. Life Sciences. 365. 123442–123442.
5.
Zhang, Peng, Yuke Chen, Zhihua Li, et al.. (2024). Modified Ileal Conduit for Pelvic Lipomatosis: Technique Description and Outcome. Urologia Internationalis. 108(4). 314–321. 1 indexed citations
6.
Zhang, Yuwei, et al.. (2024). Contribution of the Microbiome to Interstitial Cystitis/Bladder Pain Syndrome: A Mini Review. European Urology Focus. 10(6). 893–897. 1 indexed citations
7.
Zhang, Yuwei, Hao Lin, Jing Lv, et al.. (2024). Intratumoral microbiota as a novel prognostic indicator in bladder cancer. Scientific Reports. 14(1). 22198–22198. 3 indexed citations
8.
9.
Zou, Cheng, Wenchao Li, Ninghan Feng, et al.. (2024). Identification of an anaplastic subtype of prostate cancer amenable to therapies targeting SP1 or translation elongation. Science Advances. 10(14). eadm7098–eadm7098. 7 indexed citations
10.
Shan, Kai, Jiaqi Li, Yumin Qi, et al.. (2023). Cis-monounsaturated fatty acids inhibit ferroptosis through downregulation of transferrin receptor 1. Nutrition Research. 118. 29–40. 5 indexed citations
11.
Qu, Xinyu, Ying Peng, Xinyu Xu, et al.. (2023). Iodide-Enhanced Perovskite Nanozyme-Based Colorimetric Platform for Detection of Urinary Nuclear Matrix Protein 22. ACS Applied Materials & Interfaces. 15(23). 27742–27749. 10 indexed citations
12.
Zhang, Lei, Yuhui He, Zhihua Li, et al.. (2022). Analysis of the efficacy and risk factors of surgical treatment of recurrent UPJO in adults. International Urology and Nephrology. 55(6). 1493–1499. 3 indexed citations
13.
Yu, Yu‐Zhong, Daojun Lv, Chong Wang, et al.. (2022). Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Molecular Cancer. 21(1). 12–12. 108 indexed citations
14.
15.
Cheng, Hong, et al.. (2022). ASNS can predict the poor prognosis of clear cell renal cell carcinoma. Frontiers in Oncology. 12. 882888–882888. 3 indexed citations
16.
Gu, Yifeng, Yang Wang, Lei Hu, et al.. (2022). Gut Mycobiome in Patients With Chronic Kidney Disease Was Altered and Associated With Immunological Profiles. Frontiers in Immunology. 13. 843695–843695. 18 indexed citations
17.
Qu, Hongyan, Kai Shan, Chunlei Tang, et al.. (2021). A novel small-molecule fatty acid synthase inhibitor with antitumor activity by cell cycle arrest and cell division inhibition. European Journal of Medicinal Chemistry. 219. 113407–113407. 10 indexed citations
18.
Liu, Fengping, Nan Zhang, Jiang Peng, et al.. (2020). Characteristics of the urinary microbiome in kidney stone patients with hypertension. Journal of Translational Medicine. 18(1). 130–130. 36 indexed citations
19.
20.
Jia, Lingling, Dongyao Li, Ninghan Feng, et al.. (2017). Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice. Scientific Reports. 7(1). 7046–7046. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunshan Wang Breakdown of academic impact, for papers by Shiming Yang Breakdown of academic impact, for papers by Carlos Fernández-Patrón Breakdown of academic impact, for papers by Shanling Liu Breakdown of academic impact, for papers by Feng Kong Breakdown of academic impact, for papers by Xing Zhang Breakdown of academic impact, for papers by Jian Pan Breakdown of academic impact, for papers by Weijun Liu
Rankless by CCL
2026